₹5,000-crore business pipeline expected as India’s largest manufacturing expo opens in Gandhinagar 1,000+ exhibitors, 400 global participants, 100+ […]
Sun Pharma gets FDA nod for enhanced Unloxcyt™ Label
Long-term data show stronger, more durable responses in advanced skin cancer First and only PD-L1 inhibitor for aCSCC […]
Eris Lifesciences acquires remaining stake in Swiss Parenterals
Share-swap deal brings Naishadh Shah into Eris’ Top-10 Shareholder Ranks Shah to join senior management, Lead Swiss Parenterals […]
JBIC Governor’s high-level visit puts global spotlight on Dholera SIR as India’s fastest-rising semiconductor & industrial hub
Nobumitsu Hayashi hails Dholera’s world-class infrastructure, governance model and semiconductor-ready utilities during flagship review JBIC delegation assesses Tata […]
Western Gujarat Growth Frontier Reimagined
Vibrant Gujarat Regional Conference to unveil new investment corridors in Kutch & Saurashtra Mega sectors, port power & […]
Alembic Pharma secures dual USFDA approvals for Diltiazem and Dexlansoprazole
Strengthens US portfolio with back-to-back clearances across cardiac and gastro therapies New approvals add to Alembic’s growing ANDA […]
Astrazeneca & Sun Pharma join forces to expand access to hyperkalaemia therapy in India
Partnership to accelerate nationwide availability of Sodium Zirconium Cyclosilicate (SZC) Dual-brand strategy—Lokelma® and Gimliand®—to boost adoption for CKD […]
IIM Ahmedabad concludes Summer Placements 2025–26 with 100% placement
410 students placed across 25 cohorts; 50+ new recruiters join as consulting, BFSI & FMCG lead hiring surge […]
Zydus gets nod from China’s NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
NE HEALTH BUREAU AHMEDABAD, NOV 11 Zydus Lifesciences Limited on Tuesday announced it has received approval from the […]
Alembic Pharmaceuticals announces USFDA final approval for Dasatinib Tablets
NE BUSINESS BUREAU MUMBAI, NOV 7 Alembic Pharmaceuticals Limited on Thursday announced that it has received final approval […]
